iBolit

Moscow, Russia Founded: 2017 • Age: 9 yrs
Telemedicine platform is provided for clinic patient optimization and consultations.

About iBolit

iBolit is a Healthcare company based in Moscow (Russia) founded in 2017 by Dmitriy Gorozhankin and Gaponov Dmitry. Telemedicine platform is provided for clinic patient optimization and consultations. Its focus areas include HealthTech, Healthcare IT, Provider and Telemedicine Solutions. Its competitors include Doctis, MK Doctor Nearby and Qapsula; 1 of its 3 listed competitors has raised funding.

Company details

iBolit was founded in 2017 in Moscow, Russia, within the telemedicine sector. A platform is offered to support clinics in managing patient intake and readmissions. Operations include 247 chat for practitioner communication, audio and video tools for real-time consultations, automated reminders for appointments, and an integrated portal for handling consultation payments. Services are delivered digitally to facilitate healthcare access.

  • Headquarters Moscow, Russia
  • Founders Dmitriy Gorozhankin, Gaponov Dmitry
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website ibolit.pro
  • Social Facebook Instagram

People of iBolit

2 people are tracked at iBolit (2 in leadership).

NameRoleGroup
Dmitriy Gorozhankin
Co-FounderLeadership
Gaponov Dmitry
Co-FounderLeadership
Premium access

Complete people profiles for iBolit

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Competitors of iBolit

iBolit has 3 listed competitors in our database, 1 of them funded. They include Doctis, MK Doctor Nearby and Qapsula.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
doctis.ru2016Moscow, Russia
App for teleconsultation
dr-telemed.ru2007Moscow, Russia
Nearby doctors are searched for online teleconsultations on multiple disorders.
qapsula.com2015Moscow, Russia$263,000
Online telemedicine platform
Premium access

Detailed competitors of iBolit

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of iBolit

The website of iBolit (ibolit.pro) receives about 2K visits a month.

  • Monthly visits
    2K

    ▲ 223.9% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about iBolit

iBolit was founded in 2017.

iBolit is headquartered in Moscow, Russia.

iBolit was founded in 2017 in Moscow, Russia, within the telemedicine sector. A platform is offered to support clinics in managing patient intake and readmissions. Operations include 247 chat for practitioner communication, audio and video tools for real-time consultations, automated reminders for appointments, and an integrated portal for handling consultation payments. Services are delivered digitally to facilitate healthcare access.

iBolit's top competitors include Doctis, MK Doctor Nearby and Qapsula.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available